Skip to content
Letrozol neoadjuvante no CDIS episode artwork

May 11, 2020 15 min

Letrozol neoadjuvante no CDIS

from Onconews Hosted by onconews

Em mais um PODCAST ONCONEWS, o mastologista Sílvio Bromberg, do Centro de Oncologia do Hospital Israelita Albert Einstein e do departamento de Mastologia da BP Mirante, analisa Estudo de Fase II do CALGB (Alliance) que explorou a viabilidade de um ciclo de letrozol pré-operatório em pacientes com carcinoma ductal in situ (CDIS). Os resultados mostram que a estratégia resultou em alterações significativas nos exames de imagem e nos achados de histopatologia. Ouça. Referências: Hwang, E. S., Hyslop, T., Hendrix, L. H., Duong, S., Bedrosian, I., Price, E., … Hylton, N. (2020). Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor–Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance). Journal of Clinical Oncology, JCO.19.00510. doi:10.1200/jco.19.00510

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Letrozol neoadjuvante no CDIS

0:00 15:13

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Onconews?

This episode is 15 minutes long.

When was this Onconews episode published?

This episode was published on May 11, 2020.

Can I download this Onconews episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.